CANF
Price
$1.08
Change
-$0.03 (-2.70%)
Updated
Jun 5 closing price
Capitalization
15.32M
KYTX
Price
$3.08
Change
+$0.14 (+4.76%)
Updated
Jun 6, 10:42 AM (EDT)
Capitalization
127.93M
73 days until earnings call
Interact to see
Advertisement

CANF vs KYTX

Header iconCANF vs KYTX Comparison
Open Charts CANF vs KYTXBanner chart's image
Can-Fite BioPharma
Price$1.08
Change-$0.03 (-2.70%)
Volume$44.43K
Capitalization15.32M
Kyverna Therapeutics
Price$3.08
Change+$0.14 (+4.76%)
Volume$3.76K
Capitalization127.93M
CANF vs KYTX Comparison Chart
Loading...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANF vs. KYTX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANF is a Buy and KYTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CANF: $1.08 vs. KYTX: $2.96)
Brand notoriety: CANF and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CANF: 19% vs. KYTX: 208%
Market capitalization -- CANF: $15.32M vs. KYTX: $127.93M
CANF [@Biotechnology] is valued at $15.32M. KYTX’s [@Biotechnology] market capitalization is $127.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANF’s FA Score shows that 0 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • CANF’s FA Score: 0 green, 5 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CANF is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANF’s TA Score shows that 5 TA indicator(s) are bullish while KYTX’s TA Score has 4 bullish TA indicator(s).

  • CANF’s TA Score: 5 bullish, 3 bearish.
  • KYTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CANF is a better buy in the short-term than KYTX.

Price Growth

CANF (@Biotechnology) experienced а 0.00% price change this week, while KYTX (@Biotechnology) price change was +12.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.11%, and the average quarterly price growth was +3.22%.

Reported Earning Dates

CANF is expected to report earnings on Apr 14, 2025.

KYTX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($128M) has a higher market cap than CANF($15.3M). KYTX YTD gains are higher at: -20.856 vs. CANF (-33.538). CANF has higher annual earnings (EBITDA): -7.79M vs. KYTX (-108.46M). KYTX has more cash in the bank: 322M vs. CANF (4.73M). CANF has less debt than KYTX: CANF (57K) vs KYTX (9.14M). CANF has higher revenues than KYTX: CANF (667K) vs KYTX (0).
CANFKYTXCANF / KYTX
Capitalization15.3M128M12%
EBITDA-7.79M-108.46M7%
Gain YTD-33.538-20.856161%
P/E RatioN/AN/A-
Revenue667K0-
Total Cash4.73M322M1%
Total Debt57K9.14M1%
FUNDAMENTALS RATINGS
CANF: Fundamental Ratings
CANF
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CANFKYTX
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 24 days ago
85%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEMSX33.87N/A
N/A
JPMorgan Emerging Markets Equity I
LSIRX40.88N/A
N/A
ClearBridge Mid Cap IS
NUGIX35.70N/A
N/A
Nuveen Global Dividend Growth I
GLVNX78.71N/A
N/A
Invesco Global Focus R
VFMFX41.36N/A
N/A
Vanguard US Multifactor Admiral™

CANF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CANF has been loosely correlated with ALDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CANF jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
-2.70%
ALDX - CANF
46%
Loosely correlated
-0.81%
GBIO - CANF
31%
Poorly correlated
-5.63%
OABI - CANF
28%
Poorly correlated
-1.43%
KYTX - CANF
27%
Poorly correlated
+3.86%
TPST - CANF
27%
Poorly correlated
+15.16%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IMNM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
+3.86%
IMNM - KYTX
48%
Loosely correlated
+1.16%
CABA - KYTX
46%
Loosely correlated
-1.13%
CRSP - KYTX
45%
Loosely correlated
+1.37%
TRDA - KYTX
44%
Loosely correlated
+2.14%
IPSC - KYTX
44%
Loosely correlated
-0.71%
More